Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 28, 2021

View Archived Issues

Selective functional impairment of HIV-specific CD8+ T cells heralds aborted HIV control

U.S. Department of Health & Human Services patents T-cell receptors against mutated RAS

New HDAC6 inhibitors identified at Chong Kun Dang Pharmaceutical

Hanyang University discovers MAPK10 inhibitors

New PDE4 inhibitors divulged by Suzhou Longbiotech Pharmaceuticals

TIMP-1 and CKM as biomarkers of therapeutic response for exon-skipping therapies in DMD

Ninjurin-1-associated eRNA linked to glioblastoma multiforme

Association between heterozygous variant in GRM1 gene and autosomal dominant cerebellar ataxia

New proteasome inhibitors show antimalarial promise

RNA therapeutic MC-30 shows efficacy in rodent models of HNSCC

Beam Therapeutics presents in vitro data on use of cytosine base editors for hepatitis B

NINDS grant supports Sinopia's IND-enabling studies of Parkinson's candidate

Targeting nigral SRY synthesis may be therapeutic for men with Parkinson's disease

Dare Bioscience awarded NICHD grant for DARE-LARC1 user-controlled contraceptive

Oblique reports in vivo data on aG13D monoclonal antibodies for colorectal cancer

Serotonin inhibition reduces tumor growth and increases CD8+ T-cell infiltration in tumor models

Diaprost licenses theranostic antibody hu5A10 to Radiopharm

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...